Search results for "VENOUS THROMBOSIS"

showing 10 items of 183 documents

Impact of concomitant deep or superficial venous thrombosis of the legs on survival of patients with pulmonary embolism

2019

Pulmonary embolism (PE) is a frequent cause of death and morbidity. A few studies suggest that clot burden in pulmonary artery bed is related to PE patients' survival, but the impact of concomitant deep venous thrombosis and/or thrombophlebitis (DVT) on short-term survival of PE patients remains unclear. Thus, we aimed to investigate the impact of DVT on adverse outcomes in PE patients.Patients of the nationwide inpatient sample with PE (ICD-code I26) were stratified for DVT (ICD-code I80) and compared for patient characteristics, risk stratification markers, treatments and outcomes. Impact of concomitant DVT on adverse in-hospital outcomes was tested.Overall, 346,586 PE patients (53.3% fem…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyThrombophlebitis03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicine.arterymedicineHumanscardiovascular diseases030212 general & internal medicineCause of deathVenous ThrombosisInpatientsLegbusiness.industryCancermedicine.diseasePulmonary embolismVenous thrombosisConcomitantPulmonary arterySuperficial venous thrombosisFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.

2017

We sought to determine the test characteristics of an automated INNOVANCE D-dimer assay for the exclusion of pulmonary embolism (PE) and deep venous thrombosis (DVT) in emergency department (ED) patients using standard and age-adjusted cut-offs.Cross-sectional, international, multicenter study of consecutive patients with suspected DVT or PE in 24 centers (18 USA, 6 Europe). Evaluated patients had low or intermediate Wells PE or DVT scores. For the standard cut-off, a D-dimer result500 ng/ml was negative. For the age adjusted cut-off, we used the formula: Age (years) ∗ 10. The diagnostic standard was imaging demonstrating PE or DVT within 3 months. We calculated test characteristics using s…

Malemedicine.medical_specialtyAge adjustment030204 cardiovascular system & hematologyD-dimer assayFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicinebusiness.industryAge FactorsHematologyEmergency departmentVenous ThromboembolismMiddle Agedmedicine.diseasePulmonary embolismVenous thrombosisCross-Sectional StudiesMulticenter studyDecreased SensitivityBiological AssayFemalebusinessVenous thromboembolismThrombosis research
researchProduct

Serial 2-Point Ultrasonography Plus D-Dimer vs Whole-Leg Color-Coded Doppler Ultrasonography for Diagnosing Suspected Symptomatic Deep Vein Thrombosis

2008

Context Patients with suspected deep vein thrombosis ( DVT) of the lower extremities are usually investigated with ultrasonography either by the proximal veins ( 2-point ultrasonography) or the entire deep vein system ( whole- leg ultrasonography). The latter approach is thought to be better based on its ability to detect isolated calf vein thrombosis; however, it requires skilled operators and is mainly available only during working hours. No randomized comparisons are yet available evaluating the relative values of these 2 strategies. Objective To assess if the 2 diagnostic strategies are equivalent for the management of symptomatic outpatients with suspected DVT of the lower extremities.…

Malemedicine.medical_specialtyDeep veinContext (language use)VeinsSettore MED/15 - Malattie Del Sanguelaw.inventionFibrin Fibrinogen Degradation ProductsRandomized controlled triallawD-dimermedicineHumansProspective StudiesUltrasonography Doppler ColorProspective cohort studyAgedVenous ThrombosisFirst episodeLegbusiness.industrydeep vein thrombosiultrasonographyGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisSurgeryVenous thrombosismedicine.anatomical_structureD-dimerFemaleRadiologybusinessJAMA
researchProduct

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.

2015

Pulmonary embolism (PE) is the consequence of deep vein thrombosis (DVT) in 70% of all cases. Although, PE and DVT are commonly related to risk factors of Virchow's triad, both entities are linked to cardiovascular risk factors, but risk factors seem differently important in both entities.We aimed to investigate clinical profile and outcome of patients with PE history stratified by concomitant DVT.Data from the observational multi-center thrombEVAL-study were analyzed.The sample (N=2,318) comprised 295 PE patients, of whom 69.2% (N=204) had DVT. Individuals without DVT were older and had higher prevalence of concomitant atrial fibrillation (AF), chronic lung diseases, coronary artery diseas…

Malemedicine.medical_specialtyDeep veinCoronary artery diseaseRisk FactorsInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseasesAgedAged 80 and overVenous Thrombosisbusiness.industryAtrial fibrillationHematologyOdds ratiomedicine.diseaseThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureHeart failureCardiologyFemalebusinessPulmonary EmbolismThrombosis research
researchProduct

High incidence of venous thrombosis after surgery for abdominal aortic aneurysm

2009

Objective The incidence of venous thromboembolism (VT) after aortic abdominal aneurysm (AAA) surgery is imprecisely reported. On one hand, thromboprophylaxis has improved, on the other hand, AAA patients have become older and/or present worse comorbidities. Herein, we prospectively analyzed the incidence of VT in a continuous series of patients operated on for AAA repair and looked for predictive factors. Materials and Methods Between January 1, 2005, and December, 31, 2006, 193 consecutive patients (177 men and 16 women), mean age 73 (range, 47-93) underwent elective AAA repair, 137 open (71%) and 56 endovascular (29%), in our institution. Thromboprophylaxis consisted of thigh-length compr…

Malemedicine.medical_specialtyDeep veinDrug Administration ScheduleAortic aneurysmRisk FactorsmedicineHumansProspective StudiesEnoxaparinEarly AmbulationAgedUltrasonographyAged 80 and overVenous Thrombosisbusiness.industryHeparinIncidenceAnticoagulantsTransfusion ReactionPerioperativeVenous ThromboembolismMiddle Agedmedicine.diseaseThrombosisAbdominal aortic aneurysmSurgeryVenous thrombosismedicine.anatomical_structureTreatment OutcomeAnesthesiaSurgeryFemaleFresh frozen plasmaCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresStockings CompressionAbdominal surgeryAortic Aneurysm AbdominalJournal of Vascular Surgery
researchProduct

Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism

2017

Essentials The long-term risk of recurrence and death after distal deep vein thrombosis (DVT) is uncertain. We included subjects with first proximal or isolated distal DVT (IDDVT) and no pulmonary embolism. The risk of symptomatic and asymptomatic recurrence is lower after IDDVT (vs. proximal). IDDVT may be associated with a lower long-term risk of death, especially after unprovoked DVT. SummaryBackground A few studies have focused on the risk of recurrence after first acute isolated distal deep vein thrombosis (IDDVT) compared with proximal DVT (PDVT), whereas the incremental risk of death has never been explored beyond the first 3 years after acute event. Methods Our single-center cohort …

Malemedicine.medical_specialtyDeep veinKaplan-Meier Estimate030204 cardiovascular system & hematologyLower riskGastroenterologyAsymptomaticVeinsanticoagulation; death; distal deep vein thrombosis; pulmonary embolism; venous thromboembolism; Hematology03 medical and health sciences0302 clinical medicineRecurrenceRisk FactorsdeathInternal medicinemedicineHumans030212 general & internal medicineanticoagulationAgedVenous Thrombosisbusiness.industryMortality rateHazard ratioVenous ThromboembolismHematologyMiddle Agedmedicine.diseaseThrombosisSurgeryPulmonary embolismVenous thrombosisTreatment Outcomemedicine.anatomical_structureFemaledistal deep vein thrombosismedicine.symptomPulmonary EmbolismbusinessFollow-Up StudiesJournal of Thrombosis and Haemostasis
researchProduct

Measuring functional limitations after venous thromboembolism: A call to action.

2019

The main objectives of therapeutic trials in venous thromboembolism (VTE) are to prevent recurrent VTE, major bleeding and death. While these outcomes are indeed highly relevant, they are also rare and do not fully capture the overall functional outcome of VTE patients. Importantly, functional limitations after VTE are prevalent after both deep vein thrombosis and pulmonary embolism occurring in up to 50% of patients. These post-VTE syndromes are associated with a decreased quality of life, higher risk of depressive disorders, unemployment and increased utilization of healthcare resources. Because of the major impact of functional limitations on individual patients and society as a whole, d…

Malemedicine.medical_specialtyDeep veinMann Whitney U test030204 cardiovascular system & hematologyValue-based healthcare03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Postthrombotic syndromeRisk FactorsDeep vein thrombosisHealth carepulmonary hypertensionmedicineHumanscardiovascular diseasesIntensive care medicineVenous Thrombosisbusiness.industryPulmonary embolismActivities of daily livingAnticoagulantsHematologyVenous Thromboembolismmedicine.diseaseequipment and suppliesClassificationThrombosisCall to actionPulmonary embolismClinical trialmedicine.anatomical_structure030220 oncology & carcinogenesisScale (social sciences)FemalebusinessThrombosis research
researchProduct

Impact of Systemic Atherosclerosis on Clinical Characteristics and Short-Term Outcomes in Patients with Deep Venous Thrombosis or Thrombophlebitis

2020

Venous thromboembolism (VTE) and atherosclerosis are accompanied by substantial cardiovascular mortality; links between both disease entities were reported. We aimed to investigate the impact of systemic atherosclerosis on adverse outcomes in patients with deep venous thrombosis or thrombophlebitis (DVT) and to identify differences in DVT patients with and without systemic atherosclerosis.The German nationwide inpatient sample was used for this analysis. Patients admitted for DVT were included in this study and stratified by systemic atherosclerosis (composite of coronary artery disease, myocardial infarction, ischemic stroke, and/or atherosclerotic arterial diseases). We compared DVT patie…

Malemedicine.medical_specialtyDiseaseThrombophlebitisCoronary artery diseaseRisk FactorsInternal medicinemedicineHumanscardiovascular diseasesMyocardial infarctionVenous Thrombosisbusiness.industryVenous ThromboembolismGeneral MedicineThrombophlebitisAtherosclerosismedicine.diseasePulmonary embolismVenous thrombosisConcomitantHeart failureCardiologyFemalePulmonary EmbolismbusinessThe American Journal of the Medical Sciences
researchProduct

Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area.

2001

Abstract Background. Thromboembolism has been reported to be associated with inflammatory bowel disease. Aim. To evaluate the association of factor V Leiden and prothrombin gene mutation with inflammatory bowel disease in a population of patients with thromboembolic events and inflammatory bowel disease and in a control population of patients with inflammatory bowel disease without thromboembolic events. Patients and methods. A series of 18 patients with inflammatory bowel disease and a history of arterial or venous thrombosis and 45 patients with inflammatory bowel disease without thromboembolic events were evaluated for the presence of factor V Leiden and prothrombin gene mutation. Freque…

Malemedicine.medical_specialtyPathologyProthrombin gene mutationPopulationGene mutationGastroenterologyInflammatory bowel diseaseCrohn Diseasehemic and lymphatic diseasesInternal medicineThromboembolismFactor V LeidenmedicinePrevalenceHumansPoint Mutationeducationeducation.field_of_studyHepatologybusiness.industryMediterranean RegionGastroenterologyFactor VMiddle Agedmedicine.diseaseVenous thrombosisMediterranean areaColitis UlcerativeFemaleProthrombinFactor V Leiden mutationbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches.

2013

Interaction between vascular wall abnormalities, inflammatory leukocytes, platelets, coagulation factors and hemorheology in the pathogenesis of deep vein thrombosis (DVT) is incompletely understood, requiring well defined animal models of human disease. METHODS AND RESULTS: We subjected male C57BL/6 mice to ligation of the inferior vena cava (IVC) as a flow reduction model to induce DVT. Thrombus size and weight were analyzed macroscopically and sonographically by B-mode, pulse wave (pw) Doppler and power Doppler imaging (PDI) using high frequency ultrasound. Thrombus size varied substantially between individual procedures and mice, irrespective of the flow reduction achieved by the ligatu…

Malemedicine.medical_specialtyPhysiologymedicine.medical_treatmentDeep veinVena Cava InferiorInferior vena cavaMicePhysiology (medical)Internal medicineOcclusionmedicineAnimalscardiovascular diseasesThrombusLigatureVenous Thrombosisbusiness.industryHematologymedicine.diseaseThrombosisMice Inbred C57BLDisease Models Animalmedicine.anatomical_structuremedicine.veincardiovascular systemCardiologyHemorheologyRadiologyCardiology and Cardiovascular MedicineLigationbusinessBlood Flow VelocityClinical hemorheology and microcirculation
researchProduct